Results 131 to 140 of about 1,448,905 (180)

Healthy Participant Versus Patient Selection for Clinical Pharmacology Studies in Small‐Molecule Oncology Drug Development

open access: yes
Clinical and Translational Science, Volume 19, Issue 11, November 2026.
Paridhi Gupta   +3 more
wiley   +1 more source

Remibrutinib as a Therapeutic Option for Solar Urticaria

open access: yes
Photodermatology, Photoimmunology &Photomedicine, Volume 42, Issue 6, November 2026.
Joshua Mijares   +3 more
wiley   +1 more source

Case Report: Secondary neurolymphomatosis successfully treated with sequential Bruton's tyrosine kinase inhibitor and bispecific antibody therapy. [PDF]

open access: yesFront Oncol
Oura M   +11 more
europepmc   +1 more source

Covalent Bruton's tyrosine kinase inhibitor HZ-A-018 in patients with relapsed or refractory B cell malignancies: A multicenter phase I study. [PDF]

open access: yesiScience
Wu G   +13 more
europepmc   +1 more source

Evobrutinib, a covalent Bruton's tyrosine kinase inhibitor: Mass balance, elimination route, and metabolism in healthy participants. [PDF]

open access: yesClin Transl Sci, 2021
Scheible H   +10 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy